These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 35042454)

  • 1. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
    Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
    BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rictor is an independent prognostic factor for endometrial carcinoma.
    Wen SY; Li CH; Zhang YL; Bian YH; Ma L; Ge QL; Teng YC; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(5):2068-78. PubMed ID: 24966915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
    Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
    BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
    Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
    Front Immunol; 2021; 12():758004. PubMed ID: 34887861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of ESRRA in Endometrial Cancer.
    Wang S; Huo X
    Technol Cancer Res Treat; 2021; 20():1533033821992083. PubMed ID: 33525981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
    Xiong C; Wang G; Bai D
    Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 11. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
    Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
    BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
    Front Immunol; 2021; 12():788431. PubMed ID: 34970268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
    Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
    Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
    Wu Y; Wang J; Ge L; Hu Q
    Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.
    Cheng Y; Li X; Dai Y; Dong Y; Yang X; Wang J
    J Gynecol Oncol; 2021 May; 32(3):e30. PubMed ID: 33559412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
    Tang J; Ma W; Luo L
    Med Sci Monit; 2019 Nov; 25():8248-8259. PubMed ID: 31678981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
    Ying J; Wang Q; Xu T; Lyu J
    Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
    Wu H; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.